Royalty Pharma Sub-Manager, LLC VC / PE / Holdco

Location: New York, NY

CIK: 0002081668 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $242M (100.0% shares, 0.0% debt)

Holdings (4)

New Positions (1)

KLRA KAILERA THERAPEUTICS 22.4%

Value $54.09M Shares 2,455,357 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
KLRA	KAILERA THERAPEUTICS	2,455,357	$54.09M	22.4%	—	—	COM	482931102

Exited Positions (1)

BCRX BIOCRYST PHARMACEUTICALS INC 15.1%

Value $36.62M Shares 3,846,154 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BCRX	BIOCRYST PHARMACEUTICALS INC	3,846,154	$36.62M	15.1%	—	—	—	09058V103

Unchanged Positions (3)

CYTK CYTOKINETICS, INC 34.5%

Value $83.52M Shares 980,392 Est. Cost — Unrealized —

BHVN BIOHAVEN LTD 18.1%

Value $43.7M Shares 2,936,507 Est. Cost — Unrealized —

BCAX ZENAS BIOPHARMA, INC. 25.1%

Value $60.61M Shares 2,388,150 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CYTK	CYTOKINETICS, INC	980,392	$83.52M	34.5%	—	—	COM	23282W605
BHVN	BIOHAVEN LTD	2,936,507	$43.7M	18.1%	—	—	COM	G1110E107
BCAX	ZENAS BIOPHARMA, INC.	2,388,150	$60.61M	25.1%	—	—	COM	055477103